8 years
FDA Field Investigator
Conducted pharmaceutical facility inspections and evaluated quality systems from the field — where records, practices, and investigator judgment meet.

Joseph Lambert, PharmD, BCSCP
Experience on the FDA side, the compliance side, and the corporate side.
Former FDA Investigator · CDER OMQ Compliance Officer · Founder, Tailwind Pharma
Joseph Lambert spent nearly 17 years at FDA — first as a pharmaceutical field investigator, then in CDER’s Office of Manufacturing Quality — before moving into global corporate quality leadership. He brings that combined FDA and industry perspective to the moments when the right next move matters most.
If you have an FDA situation, Joseph has probably encountered it — as an investigator, compliance officer, or corporate quality leader.
Nearly 17
Years at FDA — field investigator and CDER compliance
VP
Corporate Quality Assurance in industry
Global
Inspection and quality perspective
The name Tailwind Pharma traces back to a lesson Joseph learned on a high school track in the Midwest. One rare tailwind shaved 0.4 seconds off his 100-meter time, broke the school record, and showed how much the right lift can matter at the right moment.
Today, Tailwind Pharma applies that idea to regulatory work: bring experienced judgment into the room, remove uncertainty, and help a life science team turn an obstacle into forward momentum.
“Be the discreet tailwind that helps manufacturers move through regulatory hurdles and keep quality at the center.”
The evidence, decisions, investigations, remediation, and management actions must withstand scrutiny from the field through compliance review and into sustainable operation.
8 years
Conducted pharmaceutical facility inspections and evaluated quality systems from the field — where records, practices, and investigator judgment meet.
8 years
Served in FDA’s Office of Manufacturing Quality, working through compliance decisions, inspection findings, and the evidence behind regulatory action.
Vice President
Led global quality strategy, governance, and oversight for a $4 billion worldwide pharmaceutical company across injectable biologics and complex parenteral products.
Why that matters: an investigator tests what happened, a compliance officer evaluates its significance, and an industry executive must make the correction work.
Regulatory depth matters most when it can be translated into a decision your quality unit can defend and your operation can sustain.
Doctor of Pharmacy and Board Certified Sterile Compounding Pharmacist, bridging clinical insight with manufacturing science.
Inspection and remediation experience across North America, Europe, India, and China.
Experience spanning sterile injectables, oral solid dose, APIs, CDMOs, PET, 503A and 503B compounding, suppliers, packaging, and labeling.
Quality strategy, governance, escalation, supplier oversight, and practical decisions inside a global pharmaceutical organization.
Tailwind Pharma is the consulting firm. Joseph is the senior expert doing the work, with former FDA colleagues available when a larger project needs additional depth.
Inspection support, 483 and Warning Letter response, remediation, and fractional executive quality advice.
Sterile manufacturing readiness, compounding practice, data integrity, and supplier quality oversight.
Former-FDA perspective for expert witness work, regulatory due diligence, and complex project teams.
Use a free 15-minute triage call to explain the inspection, observation, deadline, or quality decision you are facing and get an honest read on the next step.